BAX's Quality Score rose 1 point on Wed, Nov 4, to 8.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 4.2% today with medical device stocks: Neuronetics rose 23.5% after its report; 80 of 85 are up, 5.9% on average; the S&P 500 is up 1.6%; energy and AI power stocks fell.
Fell on Oct 29
Down 8% on Oct 29 while the S&P 500 fell 0.4%.
| Since its 2022 high | Down 72% |
| Latest filing | 8-K, Oct 29 |
TodayWith its group.
Fri Nov 27: Ex-dividend, $0.01 a shareAt the open. Pays Jan 4.
After its last 4 reports it closed -2.9% on average, higher 2 of 4 times.
Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means
BAX is #32 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 32 |
Net income over four quarters: BAX -$1.06B, SYK $3.73B, BDX $941M, HAE $96.3M.
Expected to report Thu Feb 11, before the open (in 99 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $3.0B, 5% more than a year ago; a profit of $0.57 a share, from a loss of $0.10.
“Third-quarter sales of $2.98 billion increased 5% on both a reported and organic basis, 1,2 reflecting growth in all segments and divisions”
BAX's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“On an adjusted basis, net income in the third quarter was $0.58 per diluted share, decreasing 16% due to a higher effective tax rate, year-over-year.”
From its results filing (SEC filing · Oct 29)
Sales fell 0.7% a year over 5 years, fiscal 2020 to 2025.
Pays $0.04 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Oct 29, 2026 | +2.1% | -7.7% | +5.0% |
| Jul 30, 2026 | +17.4% | +8.0% | +10.3% |
| Apr 30, 2026 | +4.9% | +4.0% | +0.5% |
Sales grew in six of the last seven years, to $11B in 2025. It made a profit in five of the eight years.
10 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: BAX is under 0.1% of VYM, under 0.1% of SPYI, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
“Our businesses benefit from a number of competitive advantages, including the breadth and depth of our product offerings and our strong relationships with customers, including hospitals and clinics, GPOs, IDNs, physicians and patients, many of whom self-administer home-based therapies that we supply.”
BAX scores 8 today, which Breakaway calls Average. It is #32 of 85 in Medical Devices by Quality Score, with 4 of 14 chart checks firing. Down 8% on Oct 29 while the S&P 500 fell 0.4%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
BAX scores 8 today, which Breakaway calls Average (6 to 10). That is #32 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BAX's 8.
Expected to report Thu Feb 11, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. BAX closed higher after 2 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.